Literature DB >> 13874434

[Clinical studies with 2-sulfanilamido-5-methoxypyrimidine].

P BUENGER, G KOCH.   

Abstract

Entities:  

Keywords:  SULFONAMIDES/therapy

Mesh：

Substances：

Year:  1961        PMID： 13874434

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  5 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  [Letter: On P. Naumann's article; On the current status of standardization of resistance determination in Germany].

Authors: 
Journal:  Infection       Date:  1974       Impact factor: 3.553

Review 3.  [Plasma protein binding of drugs].

Authors:  J Krieglstein
Journal:  Klin Wochenschr       Date:  1969-11-01

4.  [A sulfanilamide with an extremely slow elimination. Elimination, distribution, dosage and enteric absorption of 4-sulfanilamido-5,6-dimethoxypyrimidine in children].

Authors:  E Gladtke
Journal:  Klin Wochenschr       Date:  1965-12-15

5.  Chemotherapeutic activity of combination doses of chloroquine, pyrimethamine, and sulfamethoxy-diazine, a long-acting sulfanilamide, against Plasmodium berghei infections in mice.

Authors:  D A Berberian; R G Slighter
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.